The eligibility requirements for filing a gastroparesis claim consist of: Documented use of Ozempic, Wegovy, Rybelsus, Mounjaro, or other GLP-1 receptor agonists with prescription records or pharmacy documentation Gastroparesis diagnosis or related gastrointestinal condition (ileus, intestinal obstruction, gastric outlet obstruction) from a healthcare provider Symptoms occurring during drug use or within 30-60 days of discontinuation Medical intervention demonstrating injury severity: emergency room visits, hospitalization for at least 24 hours, or gastroenterologist consultation Persistent symptoms lasting four weeks or longer, particularly cyclic vomiting episodes No prior history of gastroparesis, gastric surgery (bypass, banding, sleeve), or conditions causing similar symptoms Medical records documenting treatment attempts and ongoing symptom management Cases filed within applicable statute of limitations (typically 1-3 years from injury discovery) The ongoing legal debate regarding diagnostic testing requirements impacts case eligibility determinations
Appetite reduction Semaglutide also reduces your appetite, which can result in consuming fewer calories and potentially lowering sodium intake
An amazing full body workout
Some BCBS insurance plans have reduced or eliminated weight loss drug coverage due to rising costs, although it may still be covered for other indications, such as cardiovascular risk reduction and liver disease (MASH)
Our licensed providers work with each patient to find the right medication, dosage, and approach based on their individual health profile and goals
Read our full review here: Mochi GLP-1 Clinic Review 8
